Horizon Kinetics Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$169K Sell
13,188
-604
-4% -$7.69K ﹤0.01% 309
2025
Q4
$124K Sell
13,792
-604
-4% -$8.31K ﹤0.01% 309
2025
Q3
$249K Buy
14,396
+604
+4% +$7.44K ﹤0.01% 284
2025
Q2
$129K Sell
13,792
-804
-6% -$6.6K ﹤0.01% 327
2025
Q1
$104K Buy
14,596
+200
+1% +$2.02K ﹤0.01% 327
2024
Q4
$168K Buy
14,396
+604
+4% +$9.43K ﹤0.01% 320
2024
Q3
$283K Sell
13,792
-604
-4% -$13.9K ﹤0.01% 281
2024
Q2
$322K Hold
14,396
0.01% 248
2024
Q1
$396K Hold
14,396
0.01% 231
2023
Q4
$439K Sell
14,396
-604
-4% -$17.4K 0.01% 217
2023
Q3
$474K Hold
15,000
0.01% 219
2023
Q2
$612K Hold
15,000
0.01% 200
2023
Q1
$559K Buy
15,000
+5,000
+50% +$196K 0.01% 208
2022
Q4
$349K Hold
10,000
0.01% 241
2022
Q3
$560K Hold
10,000
0.01% 200
2022
Q2
$518K Hold
10,000
0.01% 210
2022
Q1
$727K Hold
10,000
0.01% 202
2021
Q4
$1.18M Hold
10,000
0.03% 167
2021
Q3
$1.34M Hold
10,000
0.03% 152
2021
Q2
$1.62M Hold
10,000
0.03% 145
2021
Q1
$803K Hold
10,000
0.02% 200
2020
Q4
$544K Hold
10,000
0.02% 228
2020
Q3
$199K Hold
10,000
0.01% 337
2020
Q2
$210K Buy
+10,000
New +$170K 0.01% 338

Other funds holding NTLA